原发性多血管闭塞机械取栓的多中心分析与系统综述
本研究多中心回顾性分析了接受多靶点机械取栓的原发性多血管闭塞(pMVO)患者,并系统综述既往文献。在6081例筛查患者中仅21例符合标准(0.35%),技术再灌注率高,但90天死亡率达60%,仅20%达到mRS≤2,良好预后几乎仅见于至少含一处M2闭塞者。
要点
- pMVO接受多靶点机械取栓者极少,占筛查患者的0.35%(95%CI 0.23%-0.53%)。
- 第一与第二靶血管成功再灌注(TICI≥2b)率分别为95.2%和76.1%。
- 90天死亡率60%,仅20%达到mRS≤2,良好预后几乎仅见于含M2闭塞者。
核心结论
- 多靶点机械取栓治疗pMVO开展极少,但操作可行且安全,两处闭塞部位再灌注率均高。
- 超过半数接受治疗的患者早期死亡,良好预后可能仅见于至少包含一处M2闭塞的pMVO患者。
研究设计与样本
- 多中心回顾性研究,筛查6081例患者,21例符合纳入标准并接受多靶点机械取栓。
- 纳入的pMVO部位包括基底动脉、颈内动脉及大脑中动脉(M1和M2)。
- 同时进行系统文献综述,汇总既往pMVO机械取栓报告。
主要发现
- pMVO在接受筛查患者中占0.35%(95%CI,0.23%-0.53%)。
- 70%(14/20)报告为心源性栓塞病因。
- 第一靶血管TICI≥2b再灌注率95.2%(20/21),第二靶血管76.1%(16/21)。
- 急性住院存活者(10/21)入院NIHSS中位数21(IQR 13-27)改善至出院时8(IQR 2-20),P=0.006。
- 90天死亡率60%(12/20),仅20%(4/20)达到mRS≤2。
关键数值与推荐
- pMVO定义为累及基底动脉、颈内动脉及大脑中动脉(M1和M2)的原发性多血管闭塞。
- 成功再灌注定义为脑梗死溶栓(TICI)量表评分≥2b。
- 临床结局采用美国国立卫生研究院卒中量表(NIHSS)和改良Rankin量表(mRS)评估。
临床怎么用
- 对pMVO患者行多靶点机械取栓技术可行、再灌注率高,但需权衡极高的早期死亡风险。
- 预后咨询时应注意良好预后几乎仅见于至少含一处M2闭塞的pMVO患者。
局限性
- 本研究为多中心回顾性分析,样本量小(21例),结果解释需谨慎。
- pMVO患者罕见(0.35%),选择偏倚与缺乏对照可能影响结论外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Acute ischemic stroke caused by primary multivessel occlusions (pMVO) is a rare but devastating disease. Whether multi-target mechanical thrombectomy for pMVO is beneficial remains unknown. METHODS: Multicenter retrospective review of patients treated with multi-target mechanical thrombectomy. The following pMVO sites were included: basilar artery, internal carotid artery, and middle cerebral artery (M1 and M2). Baseline characteristics were reported together with interventional technique, technical efficacy, and safety parameters. Clinical outcomes were evaluated applying the National Institutes of Health Stroke Scale and modified Rankin Scale. A systematic literature review was performed to summarize previous reports on pMVO mechanical thrombectomy. RESULTS: Of 6081 patients screened, 21 patients met the inclusion criteria (0.35% [95% CI, 0.23%-0.53%]). In 70% (14/20) a cardioembolic cause was reported. A successful reperfusion of Thrombolysis in Cerebral Infarction scale score ≥2b was achieved in 95.2% (20/21) for the first and 76.1% (16/21) for the second target vessel. In those who survived the acute hospital stay (n=10/21), median admission National Institutes of Health Stroke Scale improved from 21 (interquartile range, 13-27) to 8 (interquartile range, 2-20) at discharge (P=0.006). Mortality was 60% (12/20) at 90 days and only 20% (4/20) of patients reached modified Rankin Scale score ≤2. Acceptable outcomes were almost exclusively observed in pMVO patients presenting with at least one M2 occlusion. CONCLUSIONS: Multi-target mechanical thrombectomy for pMVOs is rarely performed; however, the procedure appears to be feasible and safe with high reperfusion rates for both occlusion sites. More than half of all treated patients deceased early and favorable outcomes may only be expected for pMVO patients including at least one M2 occlusion.
引用
- Kaesmacher J, Meyer L, Styczen H, et al. Primary Multivessel Occlusions Treated With Mechanical Thrombectomy: A Multicenter Analysis and Systemic Literature Review. Stroke. 2020. PMID: 32654632. doi:10.1161/STROKEAHA.120.029629
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。